Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine

被引:9
|
作者
Neelapu, SS
Baskar, S
Kwak, LW
机构
[1] NCI, Expt Transplantat & Immunol Branch, Frederick, MD 21702 USA
[2] NCI, ETI Branch, Frederick, MD 21702 USA
[3] SAIC, Frederick, MD USA
关键词
D O I
10.1007/BF01470994
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Keyhole limpet hemocyanin (KLH) has been used as an immune potentiator to enhance antigen-specific responses against haptens and weak antigens including self-antigens. In the present study, we describe the optimization of the intracellular cytokine response to KLH in peripheral blood mononuclear cells (PBMC) of lymphoma and myeloma patients that were vaccinated with tumor-specific immunoglobulin (ld) conjugated to KLH. Addition of anti-CD28 antibody significantly enhanced cytokine-producing CD4(+) T cells. While fresh PBMC showed maximal cytokine response 14 h after antigen stimulation, the frozen PBMC showed maximal cytokine responses by 24 h. Supplementation or the culture medium with fetal bovine serum gave a better signal-to-noise ratio than human AB serum in the intracellular detection of cytokines. The intracellular cytokine responses correlated with the cytokine measurements by enzyme-linked immunosorbent assay (ELISA). Together these results indicate that the intracellular cytokine assay is very helpful to measure antigen-specific immune responses, and in subsequent studies, we have utilized this sensitive technique to detect immune responses against tumor antigens such as idiotype.
引用
收藏
页码:R14 / R19
页数:6
相关论文
共 31 条
  • [1] Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine
    Sattva S. Neelapu
    Sivasubramanian Baskar
    Larry W. Kwak
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : R14 - R19
  • [2] Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
    Florian Wimmers
    Nienke de Haas
    Anja Scholzen
    Gerty Schreibelt
    Elles Simonetti
    Marc J. Eleveld
    Huberdina M. L. M. Brouwers
    Marjo Beldhuis-Valkis
    Irma Joosten
    Marien I. de Jonge
    Winald R. Gerritsen
    I. Jolanda M. de Vries
    Dimitri A. Diavatopoulos
    Joannes F. M. Jacobs
    Scientific Reports, 7
  • [3] Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
    Wimmers, Florian
    de Haas, Nienke
    Scholzen, Anja
    Schreibelt, Gerty
    Simonetti, Elles
    Eleveld, Marc J.
    Brouwers, Huberdina M. L. M.
    Beldhuis-Valkis, Marjo
    Joosten, Irma
    de Jonge, Marien I.
    Gerritsen, Winald R.
    de Vries, I. Jolanda M.
    Diavatopoulos, Dimitri A.
    Jacobs, Joannes F. M.
    SCIENTIFIC REPORTS, 2017, 7
  • [4] ABNORMAL IMMUNE RESPONSE TO KEYHOLE LIMPET HEMOCYANIN (KLH) IN PATIENTS WITH MULTIPLE MYELOMA
    HARRIS, J
    ALEXANIAN, R
    HERSH, EM
    MIGLIORE, P
    ANNALS OF INTERNAL MEDICINE, 1969, 70 (05) : 1084 - +
  • [5] Glycosylation Status and Presentation Format Determines Immune Responses Induced by Keyhole Limpet Hemocyanin (KLH)
    Bi, Shuguang
    Baum, Mary
    Morse, Daniel
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [6] SPECIFIC IGG ACTIVITY OF SERA FROM EGYPTIAN SCHISTOSOMIASIS PATIENTS TO KEYHOLE LIMPET HEMOCYANIN (KLH)
    MARKL, J
    ELDIN, MN
    WINTERSIMANOWSKI, S
    SIMANOWSKI, UA
    NATURWISSENSCHAFTEN, 1991, 78 (01) : 30 - 31
  • [7] Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma
    JurincicWinkler, CD
    VonderKammer, H
    Beuth, J
    Scheit, KH
    Klippel, KF
    ANTICANCER RESEARCH, 1996, 16 (4A) : 2105 - 2110
  • [8] IMMUNOGENICITY OF SYNTHETIC TF-KLH (KEYHOLE LIMPET HEMOCYANIN) AND STN-KLH CONJUGATES IN COLORECTAL-CARCINOMA PATIENTS
    ADLURI, S
    HELLING, F
    OGATA, S
    ZHANG, SL
    ITZKOWITZ, SH
    LLOYD, KO
    LIVINGSTON, PO
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (03) : 185 - 192
  • [9] Monitoring the response to neo-antigen in patients vaccinated with keyhole limpet hemocyanin (KLH) after hematopoietic cell transplantation (HCT)
    Panoskaltsis-Mortari, A
    Berthold, M
    Curtsinger, J
    Malvey, K
    Fautsch, S
    Blazar, B
    Miller, J
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S43 - S43
  • [10] Keyhole limpet hemocyanin type 2 (KLH2):: Detection and immunolocalization of a labile functional unit h
    Gebauer, W
    Harris, JR
    Geisthardt, G
    Markl, J
    JOURNAL OF STRUCTURAL BIOLOGY, 1999, 128 (03) : 280 - 286